Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies

Fig. 8

a Immunohistochemical evaluation of CD133 and NF-kB. Images are tumor staining fields for each treatment. The low-power scale bar is 2 μm, and the high-power scale bar is 50 μm. b Quantification of melanoma tumors data compared to control (untreated cells). The levels of CD133 and NF-kB proteins reduced, though not significantly compared to the control cells *P < 0.05 and **P < 0.01

Back to article page